| Absorption | 
      | Blood-Brain Barrier | BBB- | 0.5821 | 
      | Human Intestinal Absorption | HIA+ | 0.7519 | 
      | Caco-2 Permeability | Caco2- | 0.8899 | 
      | P-glycoprotein Substrate | Non-substrate | 0.6377 | 
      | P-glycoprotein Inhibitor | Non-inhibitor | 0.9527 | 
                                                     | Non-inhibitor | 0.9369 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.9292 | 
        
            | Distribution | 
        
      | Subcellular localization | Mitochondria | 0.6713 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.8653 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.8805 | 
      | CYP450 3A4 Substrate | Non-substrate | 0.7379 | 
      | CYP450 1A2 Inhibitor | Non-inhibitor | 0.8273 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.9441 | 
        | CYP450 2D6 Inhibitor | Non-inhibitor | 0.9417 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.9346 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.9195 | 
      | CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9652 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9837 | 
                                                                    | Non-inhibitor | 0.9306 | 
      | AMES Toxicity | Non AMES toxic | 0.8597 | 
      | Carcinogens | Non-carcinogens | 0.7946 | 
      | Fish Toxicity | Low FHMT | 0.8340 | 
      | Tetrahymena Pyriformis Toxicity | Low TPT | 0.9376 | 
      | Honey Bee Toxicity | High HBT | 0.6474 | 
      | Biodegradation | Ready biodegradable | 0.9130 | 
      | Acute Oral Toxicity | IV | 0.5013 | 
      | Carcinogenicity (Three-class) | Non-required | 0.7453 |